Guardant Health, Inc.
Ticker: 1576280
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q2 FY26 | Q1 FY26 | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q3 FY24 | Q2 FY24 | Q1 FY24 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 334.98+11.0% | 301.67+13.8% | 265.20+14.3% | 232.09+14.1% | 203.47+6.3% | 191.48+8.0% | 177.24+5.2% | 168.49 |
| Total Income | 334.98+11.0% | 301.67+13.8% | 265.20+14.3% | 232.09+14.1% | 203.47+6.3% | 191.48+8.0% | 177.24+5.2% | 168.49 |
| EXPENSES | ||||||||
| Expenditure | 464.10+9.7% | 423.02+16.2% | 364.19+7.6% | 338.50+7.6% | 314.51+1.8% | 308.80+11.1% | 277.85+3.6% | 268.17 |
| Tax | 0.19-48.6% | 0.37+164.3% | 0.14+250.0% | 0.04-86.2% | 0.29+866.7% | 0.03-76.9% | 0.13-68.3% | 0.41 |
| PROFIT | ||||||||
| PBT | -119.96-7.4% | -111.70-20.6% | -92.59+7.3% | -99.86-5.3% | -94.87+11.9% | -107.72-5.1% | -102.50+10.5% | -114.58 |
| Net Profit | -120.14-7.2% | -112.08-20.9% | -92.73+7.2% | -99.90-5.0% | -95.16+11.7% | -107.75-5.0% | -102.63+10.7% | -114.99 |
| KEY METRICS | ||||||||
| OPM % | -38.55%+1.68pp | -40.23%-2.90pp | -37.33%+8.52pp | -45.85%+8.72pp | -54.57%+6.70pp | -61.28%-4.51pp | -56.77%+2.39pp | -59.16% |
| NPM % | -35.87%+1.29pp | -37.15%-2.19pp | -34.97%+8.08pp | -43.04%+3.72pp | -46.77%+9.51pp | -56.27%+1.63pp | -57.91%+10.34pp | -68.24% |
| EPS | -0.90-5.9% | -0.85-14.9% | -0.74+7.5% | -0.80-3.9% | -0.77+12.5% | -0.88-4.8% | -0.84+10.6% | -0.94 |
Corporate Events
Board MeetingGH
20262Nov
Board Meeting
Guardant Health, Inc. appointed Kevin R. Sayer as a Class II…
SEC Filing ↗ Board MeetingGH
20262Nov
Board Meeting
Grant of performance-based restricted stock units (PSUs) to …
SEC Filing ↗ Board MeetingGH
202617Jun
Board Meeting
Annual Meeting of Stockholders to vote on director elections…
SEC Filing ↗ Board MeetingGH
20268May
Board Meeting
Chief Medical Officer Resignation — Craig Eagle, M.D. resign…
SEC Filing ↗